Cost-effectiveness analysis of gestational diabetes mellitus screening in France

被引:25
|
作者
Poncet, B
Touzet, S
Rocher, L
Berland, M
Orgiazzi, J
Colin, C
机构
[1] Hospices Civils Lyon, Unite Evaluat Med Econ, Dept Med Informat, LASS,UMR 5823,CNRS, F-69424 Lyon 03, France
[2] Ctr Hosp Lyon Sud, Serv Med Interne, Hospices Civils Lyon, F-69310 Pierre Benite, France
[3] Ctr Hosp Lyon Sud, Serv Gynecol Obstet, Hospices Civils Lyon, F-69310 Pierre Benite, France
关键词
cost-effectiveness of gestational diabetes screening; decision analysis model;
D O I
10.1016/S0301-2115(02)00042-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To compare three strategies for gestational diabetes screening (i) screening of high-risk pregnant women with the 50g oral glucose tolerance test (OGTT): (ii) screening of all pregnant women with the 50 OGTT (iii) screening of all pregnant women according to the 75 g OGTT. Study design: Cost-effectiveness analysis. The outcome measures, i.e. macrosonita, prematurity, perinatal mortality, hypertensive disorders rates were estimated from published studies and the costs from a prospective study inolving 120 pregnant women. Results: Compared to the first strategy, the cost to obtain one unit of additional effectiveness with the second screening strategy. was up to I times more expensive. and with the third strategy was up to 3.7 times more expensive. Conclusion: The cost,, per case prevented reflect a favourable cost-effectiveness ratio (CER) for screening of high-risk pregnant women by 50 oral glucose test. (C) 2002 ELsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:122 / 129
页数:8
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS ANALYSIS OF HEMOCULT SCREENING
    PEDERSEN, KM
    KRONBORG, O
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1986, 46 : 67 - 67
  • [42] SCREENING FOR SCOLIOSIS - A COST-EFFECTIVENESS ANALYSIS
    MONTGOMERY, F
    PERSSON, U
    BENONI, G
    WILLNER, S
    LINDGREN, B
    SPINE, 1990, 15 (02) : 67 - 70
  • [43] Cost-effectiveness analysis in mammography screening
    vonFournier, D
    RADIOLOGE, 1996, 36 (04): : 300 - 305
  • [44] GLAUCOMA SCREENING - A COST-EFFECTIVENESS ANALYSIS
    GOTTLIEB, LK
    SCHWARTZ, B
    PAUKER, SG
    SURVEY OF OPHTHALMOLOGY, 1983, 28 (03) : 206 - 228
  • [45] COST-EFFECTIVENESS ANALYSIS OF DRUG THERAPIES FOR DIABETES MELLITUS TYPE 2 IN CHILE
    Balmaceda, C.
    Abbott, T.
    Armijo, N.
    Zamorano, P.
    Espinoza, M. A.
    VALUE IN HEALTH, 2022, 25 (12) : S127 - S128
  • [46] Cost-effectiveness analysis of alogliptin in type 2 diabetes mellitus: a payer perspective
    Patel, Dhruv
    Tai, Bik-Wai Bilvick
    Law, Anandi
    PHARMACOTHERAPY, 2013, 33 (10): : E268 - E268
  • [47] COST-EFFECTIVENESS ANALYSIS OF SAXAGLIPTIN IN THE TREATMENT OF DIABETES MELLITUS TYPE 2 IN SPAIN
    Ramirez de Arellano, A.
    Brosa, M.
    Franch, J.
    Mauricio, D.
    Alvarez, C.
    Sanchez-Zamorano, M.
    De Rivas, B.
    VALUE IN HEALTH, 2010, 13 (07) : A292 - A292
  • [48] EVOLUTION COST-EFFECTIVENESS ANALYSIS OF PHARMACEUTICAL CARE FOR TYPE 2 DIABETES MELLITUS
    Picoli, R. M.
    Pereira, L. B.
    Nunes, A. A.
    Pereira, L. R.
    Costa, A. L.
    VALUE IN HEALTH, 2017, 20 (09) : A921 - A921
  • [49] COST-EFFECTIVENESS ANALYSIS OF SAXAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN RUSSIA
    Arinina, E. E.
    Rashyd, M.
    VALUE IN HEALTH, 2012, 15 (04) : A172 - A172